Someday Sarepta and Anavex might be "working together" in some way. Because Sarepta can fix the non-functioning Sigma1 gene in the 20% Anavex is discovering can't create our Sigma1 target to begin with. I believe we can also up the functioning of that gene in older folks who have almost lost their Sigma1. Once we get it boosted to a certain point then the Anavex drug can do the rest for them. Just my theory. I mentioned it on the Investor Village Sarepta board that I believe the Sarepta people read - if almost no one else does these days! Sarepta's Yahoo board years ago was as lively as this one is now. Everyone is bored silly now because Sarepta is nothing but constant DMD and although they may well be looking at what Anavex is doing and maybe they see where they could step in, they will talk NOTHING but DMD. At least you guys don't have that problem here! You've got too much to talk about. Or bitch about. You're lucky. But I've talked too much. Don't want to wear out my welcome. And not sure what else I can add anyway!
Market Data 
Markets 
